Market One Minute Feature on BNN Bloomberg: MustGrow Biologics and Bayer AG Discusses Validation of Its TerraMG Biocontrol Technology

What happened: Market One shared a BNN Bloomberg feature on MustGrow Biologics Corp. (TSXV: MGRO) (OTCQB: MGROF) (FSE: 0C0) and Bayer AG discussing their License and Collaboration agreement for TerraMG biocontrol technology in Europe, the Middle East, and Africa. Key numbers: Bayer evaluation lasted nearly two years. Why it matters: The feature cites field trials confirming TerraMG's control of soil-borne diseases and compatibility with European application equipment, plus a first milestone payment, set against tightening European regulation on synthetic pesticides and fertilizers.

Market One shared a BNN Bloomberg feature on MustGrow Biologics Corp. (TSXV: MGRO) (OTCQB: MGROF) (FSE: 0C0) and Bayer AG discussing their License and Collaboration agreement for TerraMG biocontrol technology in Europe, the Middle East, and Africa.

The feature cites field trials confirming TerraMG's control of soil-borne diseases and compatibility with European application equipment, plus a first milestone payment, set against tightening European regulation on synthetic pesticides and fertilizers.